Lean Metabolic Dysfunction-Associated Steatotic Liver Disease: A Wolf in Sheep's Clothing
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32.4% of the global population. It is expected to be the primary cause of end-stage liver disease and liver transplantation. Obesity is a major risk factor for MASLD. Howeve... ...
